
Atsena Therapeutics Releases ATSN-301 Gene Therapy Data
Durham-based biotech company shows successful preclinical testing for its Usher Syndrome Type 1B gene therapy.
Live Poll
Is enough being done to accelerate research for treatments of inherited, currently incurable diseases?




